Short communicationEffects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines
Introduction
Numerous vaccines which protect by inducing antibody responses are currently licensed for use in humans [1], [2]. However, for some pathogens (e.g., human immunodeficiency virus and Mycobacterium tuberculosis) and tumors, antibody responses are thought to be insufficient for complete protection [3]. By comparison, few vaccines are available which protect by inducing T cell-mediated immune responses [4]. In an effort to develop vaccines which induce cell-mediated immune responses, antigen mannosylation represents a promising strategy for enhancing antigen immunogenicity by targeting mannose receptors (MRs) on antigen-presenting cells (APCs) [5]. Mannosylation of antigens can be accomplished by chemical conjugation or by exploiting the natural capacity of fungi to preferentially use mannose groups when adding O- and N-linkages [6]. Using the model antigen OVA expressed in the yeast Pichia pastoris, we have demonstrated that fungal mannosylation enhances antigen immunogenicity in the context of major histocompatibility complex (MHC) class II-restricted CD4+ T cell responses [7]. Moreover, the presence of either O-linked or N-linked mannosylation was sufficient to boost antigen-specific CD4+ T cell stimulation. Optimal protection against many tumors and pathogens is thought to require the induction of MHC class I-restricted CD8+ T cell responses [8], [9]. Recognizing the value of priming cytotoxic T lymphocyte responses, Stubbs et al. have shown that vaccination of mice with yeast engineered to express tumor antigens induced protective antigen-specific CD8+ T cell responses [10].
The purpose of this study was to evaluate the capacity of fungal mannosylation to: (1) enhance antigen immunogenicity in the context of MHC class I-restricted CD8+ T cell responses and, (2) stimulate DC proinflammatory cytokine production. Unmannosylated OVA antigens were produced in Escherichia coli; whereas mannosylated OVA antigens were produced in the yeast P. pastoris. To examine the relative contributions of the type of mannosylation, the degree of N- and O-linkages was manipulated by site-directed mutagenesis of the asparagine-X-serine/threonine sequences responsible for N-linkages and the addition of a serine/threonine-rich region to provide extensive O-linkages. We found that mannosylated OVA antigens were significantly more potent than their unmannosylated counterparts at inducing antigen-specific CD8+ lymphoproliferation. Additionally, N-linked mannosylation decreased the immunogenicity of OVA antigens, whereas extensive O-linked mannosylation was stimulatory. Surprisingly, despite their less potent capacity to stimulate antigen-specific lymphoproliferation, unmannosylated antigens stimulated higher levels of tumor necrosis factor alpha (TNF-α) and interleukin 12 (IL-12) p70 production than mannosylated antigens.
Section snippets
Materials and cell culture
All chemical reagents were purchased from Sigma–Aldrich (St. Louis, MO) unless otherwise noted. Native OVA was purchased from Worthington Biochemical Corporation (Lakewood, NJ). Heat-killed, formalin-fixed Staphylococcus aureus Cowan 1 (SAC) bacterial cells were purchased from Calbiochem (La Jolla, CA). Tissue culture media were obtained from Invitrogen Life Technologies. R10 medium consisted of RPMI 1640 supplemented with 10% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM l-glutamine and
Effect of antigen mannosylation on OT-I lymphoproliferation
To determine the relative potency of unmannosylated versus mannosylated antigens at inducing antigen-specific T cell proliferation, BMDCs were cocultured with naïve OVA-specific CD8+ T cells in the presence of recombinant OVA antigens. BSA and native OVA served as negative and positive controls, respectively. Mannosylated ppOVA and ppOVAST were significantly more potent at inducing OT-I lymphoproliferation than unmannosylated ecOVA and ecOVAST (Fig. 1A). Because ppOVA and ppOVAST were
Discussion
We evaluated the capacity of fungal mannosylation to enhance antigen immunogenicity in the context of MHC class I-restricted CD8+ T cell responses. Unmannosylated and differentially mannosylated OVA antigens were used to stimulate antigen-specific T cell proliferation. Our results demonstrated a three-fold enhancement of OVA-specific CD8+ T cell proliferation induced by mannosylated ppOVA and ppOVAST versus unmannosylated ecOVA and ecOVAST, respectively (Fig. 1A). These data extend our previous
Acknowledgements
This work was supported in part by National Institutes of Health grants RO1 AI066087 and RO1 AI25780. We thank Jennifer Dan and Dr. Karen Wozniak for help with experimental design and interpretation.
References (27)
- et al.
Memory T cells and vaccines
Vaccine
(2003) - et al.
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
J Immunol Methods
(1999) - et al.
Towards an epitope-based human vaccine for influenza
Hum Vaccine
(2005) The human papillomavirus vaccines
Acta Dermatovenerol Croat
(2006)- et al.
Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design
Expert Rev Vaccines
(2004) - et al.
Mannose receptor-targeted vaccines
Expert Opin Biol Ther
(2004) - et al.
The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins
FEMS Yeast Res
(2006) - et al.
A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity
J Immunol
(2005) - et al.
CD8+ T cell effector mechanisms in resistance to infection
Annu Rev Immunol
(2000) - et al.
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
Proc Natl Acad Sci U S A
(2005)
Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity
Nat Med
Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans
Proc Natl Acad Sci U S A
TNF protects resistant C57BL/6 mice against herpes simplex virus induced encephalitis independently of signaling via TNFR1 or TNFR2
J Virol
Cited by (48)
Exceptionally long CDR3H of bovine scFv antigenized with BoHV-1 B-epitope generates specific immune response against the targeted epitope
2016, Molecular ImmunologyCitation Excerpt :Expression of these recombinant proteins in P. pastoris for immunization may be advantageous as the addition of O-linked mannose residues may contribute to enhanced antigenicity without significantly affecting the configuration of the newly identified B epitope of the gC viral envelope protein. Indeed, mannose rich glycoproteins are known to target mannose receptors on dendritic cells that may enhance antigen-specific CD4+ T-cell responses more potently than non-mannosylated proteins (Luong et al., 2007). Both gC156 and gC156scFv1H12 induced a specific immune response in the natural bovine host and the elicited antibodies cross-recognized both the free gC156 fragment and the Ag-scFv.
Vaccine immunity against fungal infections
2014, Current Opinion in ImmunologyCitation Excerpt :Candidate vaccines comprising Glucoronoxylomannan (GXM), peptide mimotopes of GXM, cell filtrate antigens (Cnef) and protein-conjugated laminaran were shown to mediate protection by inducing antibodies and promoting Th1 cell responses (Table 1). Mannosylation of protein antigen has been shown to greatly promote anti-cryptococcal Th1 and CD8+ T cell responses and protective immunity [13]. Pneumocystis pneumonia is generally restricted to immunocompromised patients and carries a high mortality rate.
Binding of DC-SIGN to glycoproteins expressed in glycoengineered Pichia pastoris
2012, Journal of Immunological MethodsCitation Excerpt :Furthermore, Mansour and co-workers showed that β-elimination of O-mannose decreases T cell responses mediated by fungal mannoprotein by about 90%, whereas removal of N-glycans by PNGaseF or EndoH digestion did not affect immunoreactivity (Mansour et al., 2006). Additionally, another study showed that MHC Class I-restricted ovalbumin antigens with N-linked high-mannose-type glycans inhibit CD8 + T lymphocyte activation whereas extensive O-linked mannosylation was stimulatory (Luong et al., 2007). DCs can present extracellular antigens via MHC Class I in a process known as cross-presentation (Rodriguez et al., 1999).
Influence of protein expression system on elicitation of IgE antibody responses: Experience with lactoferrin
2012, ToxicologyCitation Excerpt :There is a more substantial literature supporting the impact of these sugar residues on immunogenicity (IgG antibody and T cell responses). Production of recombinant mannosylated ovalbumin (a model antigen and allergen) in yeast revealed enhanced immunogenicity with respect to CD4 and CD8 T cell proliferative responses, although antibody responses were not measured (Luong et al., 2007). Furthermore, the nature of the mannosylation was critical, with O-linked mannose residues (linked through serine/threonine) associated with increased lymphoproliferative responses whereas N-linked mannosylation resulted in decreased responses.
From memory to antifungal vaccine design
2012, Trends in Immunology